vs
Side-by-side financial comparison of FARMERS NATIONAL BANC CORP (FMNB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $71.5M, roughly 1.2× FARMERS NATIONAL BANC CORP). FARMERS NATIONAL BANC CORP runs the higher net margin — 20.5% vs -38.1%, a 58.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 3.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.2%).
Farmers National Banc Corp (OH) is a regional financial holding company based in Ohio, the United States. It offers full-spectrum retail and commercial banking products, wealth management solutions, and insurance services, primarily catering to individual consumers, small and medium-sized enterprises, and local community clients in Ohio and adjacent Midwestern U.S. regions.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
FMNB vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $71.5M | $83.1M |
| Net Profit | $14.6M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 24.8% | -4.1% |
| Net Margin | 20.5% | -38.1% |
| Revenue YoY | 3.2% | 20.2% |
| Net Profit YoY | 1.7% | -27.9% |
| EPS (diluted) | $0.39 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $71.5M | $76.4M | ||
| Q3 25 | $70.8M | $83.3M | ||
| Q2 25 | $69.8M | $79.2M | ||
| Q1 25 | $67.8M | $69.2M | ||
| Q4 24 | $69.3M | $68.2M | ||
| Q3 24 | $70.3M | $58.4M | ||
| Q2 24 | $66.5M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $14.6M | $-29.8M | ||
| Q3 25 | $12.5M | $-21.4M | ||
| Q2 25 | $13.9M | $-19.6M | ||
| Q1 25 | $13.6M | $-24.7M | ||
| Q4 24 | $14.4M | $-18.9M | ||
| Q3 24 | $8.5M | $-21.0M | ||
| Q2 24 | $11.8M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 24.8% | -40.6% | ||
| Q3 25 | 20.7% | -27.8% | ||
| Q2 25 | 23.4% | -28.0% | ||
| Q1 25 | 24.1% | -39.7% | ||
| Q4 24 | 25.5% | -28.9% | ||
| Q3 24 | 14.4% | -38.4% | ||
| Q2 24 | 21.3% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 20.5% | -39.1% | ||
| Q3 25 | 17.6% | -25.7% | ||
| Q2 25 | 19.9% | -24.7% | ||
| Q1 25 | 20.0% | -35.8% | ||
| Q4 24 | 20.8% | -27.6% | ||
| Q3 24 | 12.1% | -35.9% | ||
| Q2 24 | 17.7% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.39 | $-0.54 | ||
| Q3 25 | $0.33 | $-0.38 | ||
| Q2 25 | $0.37 | $-0.35 | ||
| Q1 25 | $0.36 | $-0.45 | ||
| Q4 24 | $0.38 | $-0.34 | ||
| Q3 24 | $0.23 | $-0.40 | ||
| Q2 24 | $0.31 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | $86.7M | $51.7M |
| Stockholders' EquityBook value | $485.7M | $347.7M |
| Total Assets | $5.2B | $487.1M |
| Debt / EquityLower = less leverage | 0.18× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $86.7M | $51.6M | ||
| Q3 25 | $86.6M | $51.6M | ||
| Q2 25 | $86.4M | $51.5M | ||
| Q1 25 | $86.3M | $51.5M | ||
| Q4 24 | $86.2M | $51.5M | ||
| Q3 24 | $86.0M | $51.4M | ||
| Q2 24 | $88.9M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $485.7M | $365.9M | ||
| Q3 25 | $465.9M | $380.3M | ||
| Q2 25 | $437.7M | $385.8M | ||
| Q1 25 | $429.1M | $389.2M | ||
| Q4 24 | $406.0M | $402.2M | ||
| Q3 24 | $439.7M | $241.2M | ||
| Q2 24 | $396.7M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $5.2B | $508.1M | ||
| Q3 25 | $5.2B | $511.5M | ||
| Q2 25 | $5.2B | $513.1M | ||
| Q1 25 | $5.2B | $519.4M | ||
| Q4 24 | $5.1B | $534.0M | ||
| Q3 24 | $5.2B | $374.1M | ||
| Q2 24 | $5.2B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.18× | 0.14× | ||
| Q3 25 | 0.19× | 0.14× | ||
| Q2 25 | 0.20× | 0.13× | ||
| Q1 25 | 0.20× | 0.13× | ||
| Q4 24 | 0.21× | 0.13× | ||
| Q3 24 | 0.20× | 0.21× | ||
| Q2 24 | 0.22× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.0M | — |
| Free Cash FlowOCF − Capex | $52.2M | — |
| FCF MarginFCF / Revenue | 73.0% | — |
| Capex IntensityCapex / Revenue | 11.0% | — |
| Cash ConversionOCF / Net Profit | 4.10× | — |
| TTM Free Cash FlowTrailing 4 quarters | $85.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $60.0M | $-10.3M | ||
| Q3 25 | $10.7M | $-6.6M | ||
| Q2 25 | $14.0M | $-15.0M | ||
| Q1 25 | $15.7M | $-17.0M | ||
| Q4 24 | $66.6M | $-32.4M | ||
| Q3 24 | $23.9M | $-18.8M | ||
| Q2 24 | $16.6M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $52.2M | $-12.2M | ||
| Q3 25 | $9.0M | $-9.5M | ||
| Q2 25 | $12.4M | $-17.8M | ||
| Q1 25 | $12.2M | $-18.8M | ||
| Q4 24 | $54.9M | $-33.6M | ||
| Q3 24 | $20.4M | $-19.0M | ||
| Q2 24 | $14.4M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 73.0% | -15.9% | ||
| Q3 25 | 12.8% | -11.4% | ||
| Q2 25 | 17.8% | -22.5% | ||
| Q1 25 | 18.0% | -27.2% | ||
| Q4 24 | 79.2% | -49.2% | ||
| Q3 24 | 29.1% | -32.6% | ||
| Q2 24 | 21.6% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 11.0% | 2.4% | ||
| Q3 25 | 2.4% | 3.4% | ||
| Q2 25 | 2.3% | 3.5% | ||
| Q1 25 | 5.2% | 2.7% | ||
| Q4 24 | 16.9% | 1.7% | ||
| Q3 24 | 4.9% | 0.4% | ||
| Q2 24 | 3.3% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.10× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 1.01× | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 4.63× | — | ||
| Q3 24 | 2.80× | — | ||
| Q2 24 | 1.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMNB
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
